Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2008 Mar 19

PMID 18347057

Citations 68

Authors

Jose R Bayascas

Stephan Wullschleger

Kei Sakamoto

Juan M Garcia-Martinez

Carol Clacher

David Komander

Daan M F van Aalten

Krishna M Boini

Florian Lang

Christopher Lipina

Lisa Logie

Calum Sutherland

John A Chudek

Janna A van Diepen

Peter J Voshol

John M Lucocq

Dario R Alessi

Affiliations

Soon will be listed here.

Abstract

PDK1 activates a group of kinases, including protein kinase B (PKB)/Akt, p70 ribosomal S6 kinase (S6K), and serum and glucocorticoid-induced protein kinase (SGK), that mediate many of the effects of insulin as well as other agonists. PDK1 interacts with phosphoinositides through a pleckstrin homology (PH) domain. To study the role of this interaction, we generated knock-in mice expressing a mutant of PDK1 incapable of binding phosphoinositides. The knock-in mice are significantly small, insulin resistant, and hyperinsulinemic. Activation of PKB is markedly reduced in knock-in mice as a result of lower phosphorylation of PKB at Thr308, the residue phosphorylated by PDK1. This results in the inhibition of the downstream mTOR complex 1 and S6K1 signaling pathways. In contrast, activation of SGK1 or p90 ribosomal S6 kinase or stimulation of S6K1 induced by feeding is unaffected by the PDK1 PH domain mutation. These observations establish the importance of the PDK1-phosphoinositide interaction in enabling PKB to be efficiently activated with an animal model. Our findings reveal how reduced activation of PKB isoforms impinges on downstream signaling pathways, causing diminution of size as well as insulin resistance.

Citing Articles

Chaperone-mediated autophagy as a modulator of aging and longevity.

Endicott S Front Aging. 2024; 5:1509400.

PMID: 39687864 PMC: 11647017. DOI: 10.3389/fragi.2024.1509400.

Diet induced insulin resistance is due to induction of PTEN expression.

Rosen N, Mukherjee R, Pancholi P, Sharma M, Solomon H, Timaul M Res Sq. 2024; .

PMID: 38978604 PMC: 11230483. DOI: 10.21203/rs.3.rs-4021885/v1.

3-Phosphoinositide-Dependent Kinase 1 as a Therapeutic Target for Treating Diabetes.

Xiang X, Shuya P, Jiamin Z, Zihan Z, Xumei Y, Jingjin L Curr Diabetes Rev. 2024; 21(4):47-56.

PMID: 38468518 DOI: 10.2174/0115733998278669240226061329.

PTEN is both an activator and a substrate of chaperone-mediated autophagy.

Zhang K, Burns C, Skinner M, Lombard D, Miller R, Endicott S J Cell Biol. 2023; 222(9).

PMID: 37418003 PMC: 10327811. DOI: 10.1083/jcb.202208150.

Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full-length protein.

Sacerdoti M, Gross L, Riley A, Zehnder K, Ghode A, Klinke S Sci Signal. 2023; 16(789):eadd3184.

PMID: 37311034 PMC: 7614687. DOI: 10.1126/scisignal.add3184.

References

Biondi R . Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. Trends Biochem Sci. 2004; 29(3):136-42. DOI: 10.1016/j.tibs.2004.01.005. View

Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M . Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol. 1998; 18(7):3708-17. PMC: 108953. DOI: 10.1128/MCB.18.7.3708. View

Lipina C, Huang X, Finlay D, McManus E, Alessi D, Sutherland C . Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3. Biochem J. 2005; 392(Pt 3):633-9. PMC: 1316304. DOI: 10.1042/BJ20051046. View

Pende M, Um S, Mieulet V, Sticker M, Goss V, Mestan J . S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol. 2004; 24(8):3112-24. PMC: 381608. DOI: 10.1128/MCB.24.8.3112-3124.2004. View

Peng X, Xu P, Chen M, Hahn-Windgassen A, Skeen J, Jacobs J . Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 2003; 17(11):1352-65. PMC: 196068. DOI: 10.1101/gad.1089403. View

Rexhepaj R, Grahammer F, Volkl H, Remy C, Wagner C, Sandulache D . Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. FASEB J. 2006; 20(13):2214-22. DOI: 10.1096/fj.05-5676com. View

Gundersen H, Jensen E . The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147(Pt 3):229-63. DOI: 10.1111/j.1365-2818.1987.tb02837.x. View

Dann S, Selvaraj A, Thomas G . mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med. 2007; 13(6):252-9. DOI: 10.1016/j.molmed.2007.04.002. View

Nobukuni T, Kozma S, Thomas G . hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling. Curr Opin Cell Biol. 2007; 19(2):135-41. DOI: 10.1016/j.ceb.2007.02.019. View

10.

McManus E, Collins B, Ashby P, Prescott A, Murray-Tait V, Armit L . The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation. EMBO J. 2004; 23(10):2071-82. PMC: 424399. DOI: 10.1038/sj.emboj.7600218. View

11.

Alessi D, Deak M, Casamayor A, Caudwell F, Morrice N, Norman D . 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol. 1997; 7(10):776-89. DOI: 10.1016/s0960-9822(06)00336-8. View

12.

Li X, Monks B, Ge Q, Birnbaum M . Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature. 2007; 447(7147):1012-6. DOI: 10.1038/nature05861. View

13.

Dummler B, Tschopp O, Hynx D, Yang Z, Dirnhofer S, Hemmings B . Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol. 2006; 26(21):8042-51. PMC: 1636753. DOI: 10.1128/MCB.00722-06. View

14.

Milburn C, Deak M, Kelly S, Price N, Alessi D, van Aalten D . Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem J. 2003; 375(Pt 3):531-8. PMC: 1223737. DOI: 10.1042/BJ20031229. View

15.

Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

16.

Mora A, Lipina C, Tronche F, Sutherland C, Alessi D . Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. Biochem J. 2004; 385(Pt 3):639-48. PMC: 1134738. DOI: 10.1042/BJ20041782. View

17.

Lucocq J . Efficient quantitative morphological phenotyping of genetically altered organisms using stereology. Transgenic Res. 2006; 16(2):133-45. DOI: 10.1007/s11248-006-9048-9. View

18.

Collins B, Deak M, Murray-Tait V, Storey K, Alessi D . In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J Cell Sci. 2005; 118(Pt 21):5023-34. DOI: 10.1242/jcs.02617. View

19.

Whiteman E, Cho H, Birnbaum M . Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002; 13(10):444-51. DOI: 10.1016/s1043-2760(02)00662-8. View

20.

Komander D, Fairservice A, Deak M, Kular G, Prescott A, Downes C . Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J. 2004; 23(20):3918-28. PMC: 524332. DOI: 10.1038/sj.emboj.7600379. View